4 217

Cited 0 times in

Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis

Authors
 Seung Hyeok Han  ;  Song Vogue Ahn  ;  Jee Young Yun  ;  Anders Tranaeus  ;  Dae-Suk Han 
Citation
 NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol.27(5) : 2044-2050, 2012 
Journal Title
 NEPHROLOGY DIALYSIS TRANSPLANTATION 
ISSN
 0931-0509 
Issue Date
2012
MeSH
Adult ; Aged ; Dialysis Solutions/therapeutic use* ; Female ; Glucans/therapeutic use* ; Glucose/therapeutic use* ; Humans ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/mortality* ; Kidney Failure, Chronic/therapy* ; Male ; Middle Aged ; Peritoneal Dialysis/methods* ; Proportional Hazards Models ; Republic of Korea ; Retrospective Studies ; Survival Rate ; Treatment Outcome
Keywords
Adult ; Aged ; Dialysis Solutions/therapeutic use* ; Female ; Glucans/therapeutic use* ; Glucose/therapeutic use* ; Humans ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/mortality* ; Kidney Failure, Chronic/therapy* ; Male ; Middle Aged ; Peritoneal Dialysis/methods* ; Proportional Hazards Models ; Republic of Korea ; Retrospective Studies ; Survival Rate ; Treatment Outcome
Abstract
BACKGROUND: Many studies have suggested clinical benefits of icodextrin in peritoneal dialysis (PD) patients regarding fluid management, glycaemic control and metabolic improvement. However, reports on whether icodextrin can improve patient and technique survival is sparse. METHODS: A total of 2163 patients from 54 centres in Korea who initiated PD from July 2003 to December 2006 were enrolled. Outcomes data were retrieved retrospectively from the Baxter Korea database. Among these patients, 641 patients who had been prescribed icodextrin for >50% of their PD duration were defined as the 'icodextrin' group and the remaining 1522 patients as the 'non-icodextrin' group. Propensity score matching yielded 640 matched pairs of patients. We compared all-cause mortality and technique failure rates between the two groups. RESULTS: There were no significant differences in age, gender, diabetes, cardiovascular comorbidity, socioeconomic status, biocompatible solution use in short dwells or centre experience between the two groups. Death occurred in 92 (14.4%) patients in the icodextrin group compared with 128 (20.0%) in the non-icodextrin group [hazard ratio (HR), 0.69; 95% confidence interval (CI), 0.53-0.90; P = 0.006]. In addition, icodextrin use was associated with a significantly lower risk of technique failure (HR, 0.60; 95% CI, 0.40-0.92; P = 0.018). The icodextrin group had fewer technique failures due to non-compliance compared with the non-icodextrin group whereas peritonitis- or ultrafiltration failure-related technique failure was not different between the two groups. CONCLUSION: This study further supports previous findings of long-term utilization of icodextrin solution improving patient and technique survival in PD patients. To confirm these results, a large randomized prospective study is warranted.
Full Text
http://ndt.oxfordjournals.org/content/27/5/2044.long
DOI
21968011
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Han, Dae Suk(한대석)
Han, Seung Hyeok(한승혁) ORCID logo https://orcid.org/0000-0001-7923-5635
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/91519
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links